Christoph Brackmann
Fortune : 3 M $ au 31/05/2026
Fortune : 3 M $ au 31/05/2026
Christoph Brackmann is Chief Financial Officer at NovoCure Ltd. since 2025.
Former roles include Global Head-IR & Head-Finance International at Shire Plc from 2017 to 2018, and Senior Vice President-Finance at Moderna, Inc. Education includes an undergraduate degree from the University of Mannheim and an MBA from SDA Bocconi School of Management.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVOCURE LTD. 0,16% | 06/04/2026 | 188 144 ( 0,16% ) | 3 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NOVOCURE LIMITED | Directeur Financier/CFO | 01/01/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | - |
| SHIRE | Public Communications Contact | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
University of Mannheim
University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
SDA Bocconi School of Management
SDA Bocconi School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national